deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL 8-arm NCT03405870

LIPIDS-P Trial Phase I/II Trial (LIPIDS-P)

The LIPid Intensive Drug Therapy for Sepsis ¬Pilot (LIPIDS-P) Phase I/II Trial

Sponsor: University of Florida

Conditions Sepsis, Severe Septic Shock
Interventions Smoflipid
Updated 18 times since 2018 Last updated: Jul 23, 2025 Started: Aug 17, 2018 Primary completion: Apr 26, 2023 Completion: Apr 26, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Sepsis, Severe and Septic Shock and is currently completed. University of Florida leads this study, which shows 18 recorded versions since 2018 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Feb 2019 · 2 months · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jul 2019 · 2 months · monthly snapshot~Jul 2019 – ~Feb 2020 · 7 months · monthly snapshot~Feb 2020 – ~Mar 2020 · 29 days · monthly snapshot~Mar 2020 – ~Aug 2020 · 5 months · monthly snapshot~Aug 2020 – ~Oct 2020 · 2 months · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Feb 2022 · 12 months · monthly snapshot~Feb 2022 – ~Jul 2024 · 29 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE1/PHASE2

    Status: Recruiting → Completed

  2. Sep 2024 — Sep 2025 [monthly]

    Recruiting PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Feb 2022 — Jul 2024 [monthly]

    Recruiting PHASE1_PHASE2

  5. Feb 2021 — Feb 2022 [monthly]

    Recruiting PHASE1_PHASE2

▶ Show 13 earlier versions

  1. Jan 2021 — Feb 2021 [monthly]

    Recruiting PHASE1_PHASE2

  2. Oct 2020 — Jan 2021 [monthly]

    Recruiting PHASE1_PHASE2

  3. Aug 2020 — Oct 2020 [monthly]

    Recruiting PHASE1_PHASE2

  4. Mar 2020 — Aug 2020 [monthly]

    Recruiting PHASE1_PHASE2

  5. Feb 2020 — Mar 2020 [monthly]

    Recruiting PHASE1_PHASE2

  6. Jul 2019 — Feb 2020 [monthly]

    Recruiting PHASE1_PHASE2

  7. May 2019 — Jul 2019 [monthly]

    Recruiting PHASE1_PHASE2

  8. Mar 2019 — May 2019 [monthly]

    Recruiting PHASE1_PHASE2

  9. Feb 2019 — Mar 2019 [monthly]

    Recruiting PHASE1_PHASE2

  10. Dec 2018 — Feb 2019 [monthly]

    Recruiting PHASE1_PHASE2

  11. Sep 2018 — Dec 2018 [monthly]

    Recruiting PHASE1_PHASE2

    Status: Not Yet Recruiting → Recruiting

  12. Jun 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE1_PHASE2

    Phase: PHASE2 → PHASE1_PHASE2

  13. Feb 2018 — Jun 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Florida
Data source: University of Florida

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations